Whole exome sequencing (WES) and RNA sequencing (RNAseq) of 28 CRC patients combined with integrated analysis of the two large CRC datasets of the TCGA and CPTAC cohorts revealed significant differences in mutational burden, variant types, and TF/pathway activity levels between MSS and MSI subtypes. This evidence concerns the gene TF and colorectal carcinoma.